v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Revenues
Costs and expenses:        
Research and development costs 60,648 210,708 152,105 329,772
General and administrative costs 714,161 798,448 1,329,644 1,646,263
Total costs and expenses 774,809 1,009,156 1,481,749 1,976,035
Loss from operations (774,809) (1,009,156) (1,481,749) (1,976,035)
Interest income 365 2,233 806 5,092
Interest expense (1,810) (4,154) (4,945) (11,340)
Foreign currency gain 581 158 660 42
Net loss $ (775,673) $ (1,010,919) $ (1,485,228) $ (1,982,241)
Net loss per common share basic $ (0.29) $ (0.45) $ (0.57) $ (0.88)
Net loss per common share diluted $ (0.29) $ (0.45) $ (0.57) $ (0.88)
Weighted average common shares outstanding basic 2,720,533 2,249,290 2,596,509 2,249,290
Weighted average common shares outstanding diluted 2,720,533 2,249,290 2,596,509 2,249,290

Source